Background-Little is known about variations in the quality of ambulatory care between urban and rural communities for patients with stable ischemic heart disease. The objectives of this study were to understand the effect of rurality on variations of ambulatory processes of care and outcomes for patients with stable ischemic heart disease. Methods and Results-A population-based cohort study was conducted, which included all Ontario patients with stable ischemic heart disease confirmed on cardiac catheterization between October 1, 2008, and September 30, 2011. Patients were categorized as rural or urban based on the Rurality Index for Ontario score. Ambulatory processes of care of interest were diagnostic testing, medication usage, and access to general/speciality physicians over a 1-year time-horizon. Primary outcome was 1-year mortality. Conclusions-Despite variation in ambulatory processes of care between urban and rural patients with stable ischemic heart disease, there were no outcome differences. (Circ Cardiovasc Qual Outcomes. 2014;7:835-843.)
S table ischemic heart disease (SIHD) is a common manifestation of cardiovascular disease, a leading cause of mortality and morbidity worldwide. [1] [2] [3] Advances in the quality of inpatient care have led to better prognoses for patients with cardiovascular disease, but there remains significant variation across regions in the quality of cardiac care and outcomes. 4 In particular, previous data have shown worse outcomes for rural patients compared with patients who live in urban areas, even after controlling for clinical factors. [5] [6] [7] Most previous studies comparing care quality and outcomes for rural and urban patients with cardiovascular disease have primarily focused on inpatient care, specifically the management of acute myocardial infarction (MI) and percutaneous coronary interventions. [8] [9] [10] [11] In contrast, there is limited data on the ambulatory management of SIHD.
Ontario is Canada's largest province with a population of over 13 million people, all of whom receive universal health coverage funded by the Ministry of Health and Long Term Care. In this geographically large and diverse jurisdiction, patients requiring coronary catheterization are transferred to 1 of 18 centralized cardiac centers for specialized care. Patients are then transferred back to their community for follow-up ambulatory cardiovascular care. Thus, in the context of the Ontario healthcare system, variations in care between urban and rural patients are significantly influenced by the care delivered in the local ambulatory care environment.
Improving the quality of ambulatory management of chronic SIHD is a key quality improvement goal for the American College of Cardiology Foundation and other subspecialty societies. 12 The development of performance indicators has been a key driver in improving the delivery of healthcare. The conceptual framework for quality of care typically consists of 3 domains -structural aspects, processes of care, and finally outcomes. 13 To date, the quality of ambulatory care in rural and urban patients, in particular process of care measures, has not been well studied. Furthermore, the clinical consequences of any variation in ambulatory care quality between rural and urban patients have not been well established.
Accordingly, the objectives of the present study were to understand the effect of rurality on ambulatory processes of care for patients with chronic SIHD and to compare outcomes for patients in rural and urban areas. We hypothesized that there would be differences in ambulatory processes of care measures in rural patients relative to their urban counterparts, which would translate into poorer clinical outcomes.
Methods

Study Patients
Ontario patients ≥20 years of age who underwent outpatient cardiac catheterization between October 1, 2008, and September 30, 2011, for the assessment of SIHD were eligible for inclusion in the study cohort. Patients were included in the study cohort if they had angiographic evidence of coronary artery disease, which was defined as left main artery stenosis of ≥50% or stenosis of ≥70% in a main epicardial coronary artery. For patients who underwent multiple catheterizations, the first was considered the index event and subsequent catheterizations were not included in the analyses. Exclusion criteria included patients whose indication for angiography was MI or investigation of valvular/structural heart disease, those identified with normal coronaries or nonsignificant SIHD, patients who suffered an MI within 90 days before catheterization, and patients with missing data.
Data Sources
Data from the Cardiac Care Network of Ontario (CCN) registry was used to identify individuals who underwent cardiac catheterization. The CCN is a network of the 18 hospitals that provide invasive cardiac care in Ontario; it maintains a prospective registry on all patients who undergo coronary angiography, as well as coronary revascularization with percutaneous coronary intervention or coronary artery bypass grafting. The CCN registry contains demographic information, cardiac risk factors, comorbidities, and details on coronary anatomy for each patient in the cohort. The information in the CCN registry has been validated by selected chart reviews and core laboratory angiographic over-read.
14 Data from the CCN registry was linked using unique encrypted patient identifiers to multiple administrative databases. The Canadian Institute for Health Information Discharge Abstract Database was used to supplement comorbidity (using the International Classification of Disease, 10th Revision code) data and to identify repeat hospitalization or MI after the index catheterization. The Registered Persons Database was used to obtain the postal code of patients undergoing cardiac catheterization and ascertain mortality. The National Ambulatory Care Reporting System was used to identify emergency department (ED) visits, and the Ontario Health Insurance Plan database was used to obtain information on diagnostic and therapeutic procedures performed and the number of physician visits for each patient in the cohort. Medication coverage for prescription medications by the Ministry of Health and Long Term Care is limited to Ontarians over the age of 65 years. This information was obtained from the Ontario Drug Benefit program database. For patients <65 years old, prescription drug coverage is privately funded and thus prescription data are not available to us. This study was approved by the Sunnybrook Health Sciences Center research ethics board.
Measure of Rurality
To quantify the degree of rurality for each patient in the cohort, the Rurality Index for Ontario (RIO) score was used. 15 . The RIO score was developed by the Ministry of Health and Long Term Care of Ontario as a method to fairly and consistently measure a community's degree of rurality based on its postal code. A larger RIO score indicates a greater degree of rurality, to a maximum score of 100. Details on the derivation of the RIO score is provided in the Data Supplement. In brief, the RIO score consists of 3 components: (1) a measure of community population and density; (2) proximity to basic healthcare; and (3) proximity to tertiary care. Equations for the calculation of all 3 components are provided in Figure 1 in the Data Supplement. Rural patients were defined as having an RIO score of ≥40, which is the cut-off used to determine the eligibility of rural communities for physician recruitment incentives by the provincial government.
Processes of Care and Outcomes Measures
The processes of care selected as variables for analysis were based on the American College of Cardiology Foundation/American Heart Association/American Medical Association-Physician Consortium for Performance Improvement 2011 performance measures for adults with SIHD. 12 Broadly, we assessed 3 categories of process measures over a 1-year period after the index angiogram. First, patients were assessed as to whether they received each of the following specific diagnostic tests or procedures: revascularization within 90 days after index angiogram; left ventricular ejection fraction assessment; stress, exercise, or nuclear stress test; repeat cardiac catheterization; hemoglobin A1C (HbA1c) measurement; and cholesterol assessment. Although diabetes mellitus screening was removed from the most recent SIHD guidelines, HbA1c was still assessed in this study because diabetes mellitus is an important comorbidity in patients with SIHD and is still a measure that may be important to compare in rural and urban patients. Second, access to physician care was measured by the total number of unique ambulatory physician visits, cardiology visits, primary care physician, and general internal medicine visits per patient within 1 year. Finally, in patients over the age of 65 years, we analyzed whether patients received the following medications within 12 months after the index angiogram: angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, antiplatelet agents, β-blockers, aldosterone receptors antagonists, and statins.
The primary outcome of interest was all-cause mortality at 1 year. Secondary outcomes were ascertained within 1 year of the index angiogram; they included MI, all-cause hospitalizations, ED visits,
WHAT IS KNOWN
• Development of quality indicators has been an important driver of improvement in cardiovascular care.
• There is a previously described gap in quality of care for cardiovascular patients treated in rural centers compared with urban centers, but this has focused mainly on in-hospital management.
WHAT THE STUDY ADDS
• The ambulatory management of rural patients is similar to that of urban patients in both process of care measures and 1-year outcomes, despite fewer visits to primary care physicians and specialists.
• One-year mortality and hospitalization of rural patients is similar to urban patients, but emergency room use is significantly higher in rural patients compared with urban patients.
• Decisions about the selection of indicators to include in report cards should consider effect on clinical outcomes and not just on processes of care.
and cardiac hospitalizations for acute coronary syndromes and heart failure.
Statistical Analysis
A comparison of baseline demographics, clinical characteristics, cardiac status/testing, and physician visits between the urban and rural group was performed using t tests for continuous variables and χ 2 tests for categorical variables.
To evaluate whether there were risk-adjusted differences in processes of care in rural patients, a multiple logistic regression analysis was performed. Variables that were used in the model included age, sex, socioeconomic status based on income level, cardiac risk factors (including diabetes mellitus, hyperlipidemia, smoking status, hypertension), comorbidities (including peripheral vascular disease, cerebrovascular disease, heart failure, dialysis), Canadian Cardiovascular Society angina classification, and high-risk ischemia evaluation on noninvasive imaging. In the assessment of medications, the analyzed sample was restricted to patients ≥65 years of age. Because of overdispersion, a negative binomial regression model was used to analyze the number of physician visits in the rural and urban groups.
Kaplan-Meier curves were produced to compare unadjusted 1-year survival of urban and rural patients. Risk-adjusted primary and secondary outcomes were compared using multiple logistic regression. The presence of collinearity in the models was assessed by producing a variance-inflation factor for each independent factor evaluated. No collinearity was noted, with all variance-inflation factors <5. SAS v9.2 (SAS Institute, Cary, NC) was used to perform the statistical analyses and a 2-tailed P value of <0.05 was used to define statistical significance.
Results
Study Cohort
A flow chart summarizing the creation of the cohort is presented in Figure 1 . The final cohort included 38 804 patients with SIHD, with 34 949 patients from urban areas (RIO<40) and 3855 from rural areas (RIO≥40). Of these, 17 587 urban patients and 2925 rural patients were ≥65 years of age.
Demographic, Clinical, and Anatomic Characteristics of Patients
Information regarding the characteristics of the rural and urban patients is highlighted in Table 1 . There was no significant difference between the mean age and gender composition between the urban and rural groups. In regards to medical comorbidities and cardiac risk factors, the rural group had a significantly greater proportion of patients with previous vascular disease (11.5% versus 9.2%; P<0.001), chronic obstructive pulmonary disease (10.4% versus 6.5%; P<0.001), hypertension (88.1% versus 86.5%; P=0.008), and smoking (35.5% versus 31.1%; P<0.001), although urban patients had a higher rate of diabetes mellitus (44.2% versus 41.5%; P=0.002). Rural patients also had a significantly greater mean Charlson index score (P<0.001), suggesting a higher degree of morbidity. Despite these statistically significant differences in patients, the overall absolute differences between the groups of patients is small. Urban patients had higher rates of left ventricular ejection fraction assessment, exercise, or nuclear stress test before cardiac catheterization than rural patients.
Processes of Care
Diagnostic Tests A summary of 1-year diagnostic testing and procedures is provided in Table 2 . In the unadjusted analysis, a significantly smaller proportion of rural patients had HbA1c (58.6% versus 
Physician Visits
Outcomes
Kaplan-Meier curves with 1-year survival curves are provided in Figure 2 . The overall mortality for the entire cohort at 1-year postangiogram was 2.6%, and the unadjusted mortality was higher at 1 year for rural patients (3.2% versus 2.6%; P=0.017). After adjustment, however, there was no significant difference in 1-year mortality (OR=1.15; 95% CI, 0.94-1.41;
P=0.163).
In terms of the secondary unadjusted outcomes, there was no difference between rural and urban patients in cardiac hospitalizations (47.2 versus 46.3%; P=0.25). However, a greater proportion of rural patients visited the ED (59.1% versus 
Comparisons of Rural (RIO score 40-70) versus Very Rural Patients (RIO >70).
We aimed to determine if any differences in care existed between patients in communities with an RIO score of 40 to 70 and patients in very remote communities with RIO scores of >70. Appendix 1 shows the baseline characteristics between 3 groups: urban, RIO 40 to 70 and RIO >70. Appendix 2 shows a similar pattern of utilization in RIO >70 patients as in RIO 40 to 70. Appendix 3 shows that very rural patients have even fewer total physician visits, cardiology, primary care, and internal medicine visits than RIO 40 to 70 patients.
Discussion
The management of coronary artery disease has changed significantly in recent years, shifting from an acute condition, managed predominantly on an inpatient basis, to a chronic disease, managed in predominantly ambulatory setting. Therefore, outpatient management of patients with SIHD has become of critical importance and a focus of quality improvement efforts. In this study, we compared the ambulatory management of SIHD for Ontario patients in rural and urban areas.
We found some differences in the processes of care between urban and rural patients, in particular laboratory testing for diabetes mellitus and lipid levels and access to physicians. However, these did not translate into any differences in riskadjusted mortality or hospitalization, although rural patient were significantly more likely to use the ED for care than urban counterparts. Understanding whether this pattern of healthcare utilization is associated with increased healthcare costs is an area for future research. As previously mentioned, ambulatory cardiovascular care has been the subject of substantial quality improvement efforts, including the American Heart Association's Get with the Guidelines program. 16 Previous literature suggested rural patients faced challenges in accessing medical services and may receive suboptimal cardiac care as a result. Although our study does suggest less access to physicians, the overall clinical differences in process outcomes between urban and rural patients were relatively small. Although cholesterol and HbA1c testing was performed less frequently in rural patients, all other processes of care were similar. One caveat worth mentioning is that laboratory data conducted in hospitals may not be captured through administrative data, and it is possible that the lower rates in rural patients may reflect patients having their testing done predominantly in hospitals compared with community-based laboratories, though this limitation cannot be substantiated. Furthermore, we recognize that given our large sample size, differences that are not clinically significant may be statistically significant. Variables adjusted for age, gender, renal dysfunction, previous MI, previous stroke, previous vascular disease, COPD, Charlson index, hyperlipidemia, diabetes mellitus, hypertension, smoking, Canadian Cardiovascular Society Angina Score, location of significant epicardial coronary artery stenosis, left ventricle ejection fraction, exercise ECG before cardiac catheterization, functional imaging before cardiac catheterization.
ACEI indicates angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CI, confidence interval; and RIO, Rurality Index for Ontario In terms of medication use, only statins were used significantly less frequent in rural patients. However, the overall proportion of rural patients on statins was still over 90%, suggesting good uptake of these medications compared to previous studies looking at statin use. [17] [18] [19] These findings suggested that the care gap between urban and rural patients was not as significant as initially thought, and that efforts to improve the quality of cardiovascular care have not only benefited patients in urban environments. The relatively low rate of antiplatelet use across both groups may be because aspirin is often purchased over the counter and may be underreported in administrative data.
Although there may be differences in the processes of care between urban and rural patients, we did not find these differences translated into differences in clinical outcomes, such as 1-year mortality or MI rates. One caveat to this is that cardiac event rates in this study were low and greater follow-up may be required to detect differences in outcomes.
The lack of a difference in clinical outcomes is significant from a public policy perspective, as quality improvement programs, including public report cards and performance-based initiatives, are becoming more widespread. These report cards tend to focus on improving process of care measures, as those are often the easiest to collect and affect through knowledge translation efforts. [20] [21] [22] We would argue that in order for process of care measures to be relevant, they should have an effect on either clinical outcomes or improve the efficiency of healthcare delivery by improving economic outcomes. The link between processes of care and either clinical or economic, however, is uncertain in several disease conditions. A recent review of quality improvement reporting in cardiovascular disease found that the link between process measure improvement and improved outcomes is limited at best, and the evidence of this linkage is most commonly found in hospitalized patient, such as post-MI patients. 23 There is currently a paucity of data on the effect of process measure improvement on outcomes in ambulatory cardiovascular care and as such should be the focus of further research.
Despite the equivalent clinical outcomes, we found that rural patients access health services differently than their urban counterparts. This is consistent with previous studies that have found increased use of EDs by rural patients compared with urban ones. Rural patients have been shown to have poorer access to primary care and specialty care than urban patients, and often this is because of a lower physician supply in rural areas compared with urban ones. 24 In contrast, rural inhabitants were more likely to depend on the ED for their care. This was the most prominent difference between rural and urban patients. Our results, in contrast to previous studies, did not show a difference in hospital admissions for rural versus urban patients, despite higher ED use. This may be because stable coronary disease, in contrast to some ambulatory sensitive conditions, such as heart failure, has a lower hospitalization rate. Thus, although ED use is often looked at adversely, in many of these communities with scarce physician resources, the ED is often a place where some patients access primary care services. This may be appropriate in some areas like in remote, rural areas of the province. Although there is often an emphasis on achieving uniformity in access to healthcare resources, the results of this study showed that differences in the processes of care may not lead to poorer outcomes. Variations in care, therefore, may not be synonymous with a care gap and may actually be an appropriate difference in care because of the resources available in large diverse jurisdictions. These data are consistent with previous literature, suggesting a greater acceptance of variations in healthcare under specific contexts, as long as there is no adverse effect on patient outcomes in SIHD. 25 So we would suggest that increased ED use itself, in the absence of data showing effect on patient outcomes of health system costs in this specific context, is not necessarily a marker of suboptimal care. 26, 27 As such, future research to evaluate the relationship between ED use and health system costs should be explored.
Our study complements the previous literature in this area. Most previous studies have suggested that quality of care gaps exist between urban and rural patients, both in terms of access to physicians and processes of care measures; however, these have focused on inpatients. In a study of patients discharged post MI, Vanasse and colleagues found similar rates of medication use, but fewer cardiology visits and higher cardiac readmission rates. 26 Another study by Joynt and colleagues looked at a cohort of inpatients admitted to rural hospitals for acute MI and found rural patients had significantly higher 30-day mortality rates. 11 There is a paucity of data on ambulatory care in cardiovascular disease because the data available focused on different populations, such as heart failure or primary prevention cohorts. [26] [27] [28] [29] [30] [31] In one of the few studies of a secondary prevention cohort, a recent study by Shi and colleagues found no different in late outcomes between rural and urban patients who underwent coronary artery bypass surgery. 32 Our study, similar to the study by Shi and colleagues, used a clearly defined population of patients with coronary disease, who were managed with medical therapy in contrast to revascularization.
Our study must be interpreted in the context of several limitations in this study. We used large, administrative databases that did not include some potentially important clinical information such as blood pressure or blood results, such as cholesterol levels. For ED visits, we were not able to ascertain whether the visit was a true emergency or whether the visit served as an adjunct for a nonurgent primary care visit. We could not assess physician or healthcare-specific factors, such as presence of cardiologists or other speciality clinics within a specific community that may disproportionately influence care in a specific area. Finally, though this is a large population-based study, it is possible that because of low event rates of the primary outcome, that the study was underpowered to determine differences in the primary outcome. Despite these limitations, this study has identified ambulatory patterns of care differences in a defined cohort that could be generalizable to other large and diverse jurisdictions.
In conclusion, we found variations in processes of care and access to health services between urban and rural patients, but these variations did not seem to affect clinical outcomes. Greater study between the link between process of care metrics, outcomes, and costs are needed in cardiac patients before widespread implementation of performance measures and associated incentives.
